00

Jilin Aodong Pharmaceutical Group Co LtdSHE 000623 Stock Report

Last reporting period 30 Sep, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

2.422

Small

Exchange

XSHE - Shenzhen Stock Exchange

000623.SZ Stock Analysis

00

Avoid

Based on Eyestock quantitative analysis, 000623.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

48/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

28.7 %

Greatly undervalued

Market cap $B

2.422

Dividend yield

4.52 %

Shares outstanding

1 135.45 B

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Yanbian, Jilin and currently employs 4,613 full-time employees. The Company’s main products include capsules, granules, oral liquid, tablets, ointments, powder, syrup, pills, medicated wine and herbal decoction pieces, among others. The firm is also involved in the production of health food and food, as well as breeding, planting and other businesses. The firm mainly distributes its products in domestic market.

View Section: Eyestock Rating